Canada Markets close in 56 mins

Cann Group Limited (CAN.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.3850+0.0050 (+1.32%)
At close: 3:45PM AEDT

Cann Group Limited

Walter & Eliza Hall Inst. of Medical Res
4 Research Avenue La Trobe University
Bundoora, VIC 3083
Australia
61 3 9095 7088
http://www.canngrouplimited.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Peter Crock M.B.A., MBAChief Exec. Officer324.36kN/AN/A
Mr. Greg BullockChief Financial Officer444.63kN/AN/A
Mr. Shane DuncanChief Operating Officer298.44kN/AN/A
Mr. Geoff AldredChief Projects & Information Officer3.76MN/AN/A
Ms. Geraldine T. Farrell B.Sc., FCIS, L.L.B., L.L.M.Chief Compliance Officer & Company Sec.275.66kN/A1970
Mr. Clive FanningHead of Investor RelationsN/AN/AN/A
Mr. Steven NotaroHead of LegalN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Cann Group Limited engages in research and development, cultivation and production, manufacturing, clinical evaluation, processing, packaging, and distribution and supply of medicinal cannabis for various diseases and medical conditions in Australia. The company was founded in 2014 and is based in Bundoora, Australia.

Corporate Governance

Cann Group Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.